Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17135006 | PIGMENT MIXTURE | December 2020 | December 2024 | Abandon | 47 | 0 | 1 | No | No |
| 17123625 | BIOACTIVE WOUND DRESSING | December 2020 | February 2023 | Abandon | 26 | 2 | 0 | No | No |
| 17120007 | SELF-EMULSIFYING NANO-EMULSIONS | December 2020 | February 2024 | Abandon | 38 | 4 | 0 | No | No |
| 17118509 | NANOSCALE COATINGS FOR ENCAPSULATION OF BIOLOGICAL ENTITIES | December 2020 | February 2023 | Allow | 26 | 0 | 0 | Yes | No |
| 17081445 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | October 2020 | March 2023 | Allow | 29 | 0 | 0 | No | No |
| 17066149 | POROUS CARBON MATERIAL COMPOSITES AND THEIR PRODUCTION PROCESS, ADSORBENTS, COSMETICS, PURIFICATION AGENTS, AND COMPOSITE PHOTOCATALYST MATERIALS | October 2020 | March 2023 | Allow | 29 | 1 | 0 | No | No |
| 17024486 | MTORC MODULATORS AND USES THEREOF | September 2020 | September 2021 | Allow | 12 | 2 | 1 | Yes | No |
| 16981786 | ANTIBACTERIAL ANTIFUNGAL FIBER STRUCTURE | September 2020 | August 2024 | Abandon | 47 | 2 | 0 | Yes | No |
| 16979290 | A STABLE AGROCHEMICAL COMPOSITION | September 2020 | August 2024 | Abandon | 47 | 2 | 0 | No | No |
| 15733574 | Polyamine Prodrugs And Polyamine Prodrug Formulations | September 2020 | June 2024 | Abandon | 46 | 0 | 1 | No | No |
| 16991628 | BIODEGRADABLE SUPPORTING DEVICE | August 2020 | November 2023 | Allow | 39 | 3 | 0 | No | No |
| 16935027 | OCULAR DEVICE DELIVERY METHODS AND SYSTEMS | July 2020 | August 2021 | Allow | 13 | 2 | 1 | Yes | No |
| 16920789 | COMPOSITIONS CONTAINING LATEX PARTICLES AND INORGANIC METAL OXIDES | July 2020 | October 2021 | Abandon | 15 | 2 | 0 | No | No |
| 16918704 | CONTROLLED-RELEASE TABLETS, METHOD OF MAKING, AND METHOD OF USE THEREOF | July 2020 | February 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 16958659 | Heterocyclic Amides as Kinase Inhibitors | June 2020 | July 2023 | Allow | 37 | 0 | 0 | No | No |
| 16955847 | COSMETIC COMPOSITION COMPRISING SILICONE MATERIALS | June 2020 | March 2024 | Allow | 45 | 1 | 1 | No | No |
| 16904097 | BIOCOMPATIBLE FIBER TEXTILES FOR IMPLANTATION | June 2020 | October 2021 | Allow | 16 | 1 | 1 | No | No |
| 16898309 | COMPOSITIONS CONTAINING HC-HA/PTX3 COMPLEXES AND METHODS OF USE THEREOF | June 2020 | July 2022 | Allow | 26 | 1 | 0 | No | No |
| 16893597 | BIODEGRADABLE SUPPORTING DEVICE WITH A RADIO-OPAQUE MARKER | June 2020 | August 2021 | Abandon | 14 | 1 | 1 | No | No |
| 16767703 | HYDROPHOBIC POLYMERS AS OIL RHEOLOGY MODIFIERS FOR AGROCHEMICAL FORMULATIONS | May 2020 | February 2024 | Allow | 45 | 3 | 0 | Yes | No |
| 16766840 | METHOD FOR PRODUCING POLYETHERESTER POLYOLS | May 2020 | December 2023 | Abandon | 42 | 0 | 1 | No | No |
| 16880634 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | May 2020 | November 2023 | Abandon | 42 | 5 | 1 | Yes | No |
| 16761889 | ANTIMICROBIAL DRESSING | May 2020 | December 2023 | Abandon | 43 | 3 | 0 | No | No |
| 16847000 | SUPERPOROUS HYDROGELS, METHODS OF MAKING THE SAME, AND ARTICLES INCORPORATING THE SAME | April 2020 | March 2024 | Abandon | 47 | 6 | 1 | Yes | No |
| 16844222 | ELECTROACTIVE SUPRAMOLECULAR POLYMERIC ASSEMBLIES, METHODS OF MAKING ELECTROACTIVE SUPRAMOLECULAR POLYMERIC ASSEMBLIES, AND METHODS OF USING ELECTROACTIVE SUPRAMOLECULAR POLYMERIC ASSEMBLIES | April 2020 | January 2021 | Allow | 9 | 1 | 0 | Yes | No |
| 16843376 | UNIVERSAL CARDIOPLEGIC SOLUTION (VARIANTS) | April 2020 | December 2020 | Allow | 9 | 2 | 0 | Yes | No |
| 16754367 | HYDROGEL BEADS | April 2020 | February 2022 | Allow | 22 | 1 | 1 | Yes | No |
| 16826577 | EMBOLIC MICROSPHERES AND METHODS | March 2020 | November 2023 | Abandon | 44 | 2 | 1 | Yes | Yes |
| 16626997 | FILM-FORMING AGENT FOR COSMETICS AND COSMETICS CONTAINING SAME | March 2020 | December 2021 | Abandon | 24 | 2 | 0 | No | No |
| 16648827 | POWDERY COMPOSITION | March 2020 | June 2022 | Abandon | 27 | 3 | 1 | Yes | No |
| 16817299 | PROGRAMMABLE LIQUID, GEL AND BIOHYBRID COMPARTMENTS AND METHODS OF USE | March 2020 | October 2022 | Allow | 31 | 4 | 1 | No | No |
| 16812700 | COMPOSITIONS AND METHODS FOR RESHAPING KERATIN-RICH SUBSTRATES AND FORMING ADHERENT FLEXIBLE FILMS | March 2020 | January 2022 | Allow | 22 | 2 | 1 | Yes | No |
| 16642993 | NUCLEIC ACID-LOADED UNIT POLYION COMPLEX | February 2020 | February 2022 | Allow | 23 | 3 | 0 | Yes | No |
| 16803494 | TISSUE CUFF | February 2020 | April 2024 | Abandon | 49 | 1 | 1 | No | No |
| 16800461 | REMOVABLE FILM FORMING GEL COMPOSITIONS AND METHODS FOR THEIR APPLICATION | February 2020 | January 2021 | Abandon | 11 | 1 | 0 | No | No |
| 16640364 | ADHESION PREVENTION MATERIAL | February 2020 | March 2024 | Abandon | 49 | 4 | 0 | No | No |
| 16794367 | TWO-STEP REACTIVE LIP SYSTEM | February 2020 | March 2023 | Abandon | 37 | 5 | 0 | No | No |
| 16638857 | ANTIMICROBIAL/ANTIVIRAL COMPOSITION | February 2020 | April 2024 | Abandon | 50 | 5 | 2 | Yes | No |
| 16638897 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | February 2020 | March 2022 | Allow | 25 | 2 | 1 | Yes | No |
| 16636127 | Adhesion Materials and Methods of Manufacture | February 2020 | December 2024 | Abandon | 58 | 2 | 1 | No | No |
| 16777950 | NEGATIVE PRESSURE WOUND DRESSING AND NEGATIVE PRESSURE WOUND TREATMENT DEVICE | January 2020 | October 2023 | Abandon | 44 | 0 | 1 | No | No |
| 16633951 | WOUND DRESSING COMPRISING HYALURONIC ACID-CALCIUM AND POLYLYSINE AND MANUFACTURING METHOD THEREFOR | January 2020 | April 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16633507 | ELECTROSPUN NANOFIBERS AND MEMBRANE | January 2020 | June 2023 | Allow | 41 | 1 | 1 | Yes | No |
| 16741558 | UV-PROTECTIVE COMPOSITIONS | January 2020 | December 2020 | Abandon | 11 | 4 | 0 | Yes | No |
| 16627094 | POLYMER FOR DELIVERY OF BIOLOGICALLY ACTIVE MATERIALS | December 2019 | June 2022 | Allow | 30 | 1 | 0 | Yes | No |
| 16625046 | TISSUE REPAIR LAMINATES | December 2019 | October 2023 | Allow | 46 | 6 | 0 | Yes | No |
| 16622056 | PROCESS FOR PREPARING ORGANOPOLYSILOANE GELS | December 2019 | January 2023 | Allow | 38 | 0 | 1 | Yes | No |
| 16621011 | ANTIMICROBIAL POLYMER COMPOSITION | December 2019 | July 2023 | Allow | 43 | 6 | 1 | Yes | No |
| 16619633 | HIGH-THROUGHPUT SYNTHESIS OF BIOMOLECULE-POLYMER CONJUGATES | December 2019 | December 2024 | Abandon | 60 | 4 | 1 | Yes | No |
| 16704993 | MULTIFUNCTIONAL HYBRID AEROGELS | December 2019 | September 2023 | Abandon | 46 | 1 | 1 | No | No |
| 16703086 | SELF-EXPANDABLE STENT AND METHOD OF PRODUCING THE SAME | December 2019 | July 2024 | Abandon | 55 | 5 | 1 | No | No |
| 16700130 | NON-IONIC COACERVATES FOR DRY, HUMID AND WET ADHESION | December 2019 | February 2021 | Allow | 15 | 2 | 0 | No | No |
| 16699138 | COMPOSITE FIBER | November 2019 | May 2023 | Abandon | 41 | 2 | 1 | No | No |
| 16616270 | USE OF SPECIFIC POLYMERS TO BRING ABOUT AN ANTI-POLLUTION EFFECT | November 2019 | November 2021 | Abandon | 23 | 1 | 1 | No | No |
| 16616203 | ALKYLENE OXIDE DERIVATIVES, WETTING AGENT, SOLUBILIZING AGENT, AND SOLUBILIZING COMPOSITION | November 2019 | February 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16616437 | Multifunctional Treatment And Diagnostic Compositions And Methods | November 2019 | March 2022 | Allow | 27 | 3 | 1 | Yes | No |
| 16690571 | BIOINERT BODY | November 2019 | December 2022 | Abandon | 37 | 1 | 0 | No | No |
| 16687789 | POLYMERIC SYSTEMS AND USES THEREOF IN THERANOSTIC APPLICATIONS | November 2019 | November 2023 | Abandon | 48 | 2 | 1 | No | No |
| 16614307 | LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY | November 2019 | June 2023 | Abandon | 43 | 4 | 0 | No | Yes |
| 16683306 | DISPOSABLE MEDICAL DEVICE FOR MEDICATION OF SKIN LESIONS AND METHOD THEREFORE | November 2019 | May 2024 | Abandon | 54 | 3 | 1 | No | No |
| 16681085 | MEDICAL IMPLANT WITH POROUS PLASMA POLYMER COATING | November 2019 | August 2023 | Abandon | 45 | 2 | 1 | No | No |
| 16611787 | DYE COMPOSITION BASED ON COPOLYMERS DERIVED FROM THE POLYMERIZATION OF AT LEAST ONE CROTONIC ACID MONOMER OR CROTONIC ACID DERIVATIVE AND OF AT LEAST ONE VINYL ESTER MONOMER AND SILICONE, AND PROCESS FOR DYEING KERATIN FIBERS USING SAME | November 2019 | December 2022 | Abandon | 37 | 3 | 1 | Yes | Yes |
| 16675417 | METHOD FOR GENTLE, CHEMICAL HAIR TREATMENT | November 2019 | August 2021 | Allow | 30 | 1 | 0 | Yes | No |
| 16609544 | ENHANCED SOLUBILITY DRUG-CONTAINING FORMULATIONS | October 2019 | January 2023 | Allow | 39 | 2 | 1 | Yes | No |
| 16607180 | SEALING AGENT FOR GENITALS | October 2019 | February 2022 | Abandon | 28 | 1 | 0 | Yes | No |
| 16594878 | MICROCAPSULES AND METHODS OF USING THE SAME | October 2019 | August 2022 | Allow | 35 | 1 | 1 | Yes | No |
| 16585484 | Biocompatible Polycaprolactone Fumarate Formulations | September 2019 | June 2021 | Abandon | 20 | 2 | 0 | No | No |
| 16498595 | REVERSE THERMAL GELS AND THEIR USE AS VASCULAR EMBOLIC REPAIR AGENTS | September 2019 | January 2023 | Allow | 40 | 2 | 1 | Yes | No |
| 16541570 | POLYMER BEAD | August 2019 | September 2022 | Abandon | 37 | 4 | 1 | Yes | No |
| 16515946 | NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY | July 2019 | January 2023 | Allow | 42 | 3 | 1 | Yes | Yes |
| 16508637 | RAPIDLY DISINTEGRATING ORAL DISSOLVABLE FILM | July 2019 | January 2022 | Allow | 31 | 4 | 0 | Yes | No |
| 16477417 | NONWOVEN MATERIAL FOR CLEANING AND SANITIZING SURFACES | July 2019 | May 2023 | Abandon | 46 | 2 | 0 | No | No |
| 16456023 | DUAL PHASE PRODUCTS | June 2019 | November 2022 | Allow | 41 | 3 | 0 | Yes | No |
| 16473896 | Absorbable Iron-Based Instrument | June 2019 | February 2023 | Allow | 44 | 4 | 0 | Yes | No |
| 16473267 | STENT MADE OF A BIO-DEGRADABLE MAGNESIUM ALLOY WITH A MAGNESIUM FLUORIDE COATING AND AN ORGANIC COATING | June 2019 | July 2023 | Allow | 49 | 5 | 0 | Yes | No |
| 16444206 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | June 2019 | February 2020 | Allow | 8 | 1 | 0 | No | No |
| 16445000 | WAX FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF | June 2019 | November 2020 | Allow | 17 | 2 | 0 | Yes | No |
| 16467627 | DENTAL COMPOSITION | June 2019 | November 2023 | Allow | 53 | 4 | 1 | No | No |
| 16466872 | Composition comprising polyurethane microcapsules comprising cinmethylin | June 2019 | July 2021 | Abandon | 25 | 0 | 1 | No | No |
| 16463038 | SEED COATING COMPOSITION | May 2019 | December 2021 | Allow | 31 | 2 | 1 | Yes | No |
| 16419815 | BIODEGRADABLE SUPPORTING DEVICE WITH A RADIO-OPAQUE MARKER | May 2019 | January 2022 | Abandon | 32 | 4 | 1 | No | No |
| 16412047 | METHOD FOR DELIVERING PHARMACEUTICAL NANOPARTICLES TO CANCER CELLS | May 2019 | March 2020 | Allow | 10 | 1 | 0 | No | No |
| 16410665 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | May 2019 | May 2021 | Abandon | 24 | 4 | 0 | No | No |
| 16393597 | PHARMACEUTICAL COMPOSITION COMPRISING ELECTROHYDRODYNAMICALLY OBTAINED FIBRES, THE COMPOSITION HAVING IMPROVED RESIDENCE TIME ON THE APPLICATION SITE | April 2019 | November 2022 | Abandon | 43 | 3 | 0 | Yes | Yes |
| 16344078 | USE OF CATIONIC POLYMER HAVING QUATERNARY AMMONIUM GROUPS FOR THE PROTECTION OF HAIR AGAINST UV DAMAGE | April 2019 | April 2023 | Abandon | 47 | 3 | 1 | No | No |
| 16341726 | COLLAGEN AND COLLAGEN LIKE PEPTIDE BASED HYRDOGELS, CORNEAL IMPLANTS, FILLER GLUE AND USES THEREOF | April 2019 | April 2022 | Allow | 36 | 2 | 1 | Yes | No |
| 16376552 | METHODS OF PRODUCING OPTIMIZED GENE-ACTIVATED MATERIALS | April 2019 | January 2024 | Allow | 57 | 4 | 1 | Yes | Yes |
| 16339293 | SILICONE RESIN-LINEAR COPOLYMER AND RELATED METHODS | April 2019 | December 2021 | Abandon | 33 | 2 | 1 | No | No |
| 16338330 | PHOSPHORYLATED TRI-BLOCK COPOLYMERS WITH ANTI-MICROBIAL PROPERTIES | March 2019 | September 2022 | Allow | 42 | 3 | 1 | No | No |
| 16338103 | COMPOSITIONS OF POLYMERIC NANOWIRES AND METHODS OF MAKING AND USING THEREOF | March 2019 | November 2021 | Allow | 31 | 3 | 0 | Yes | No |
| 16365591 | POLYURETHANE/UREA COMPOSITIONS | March 2019 | January 2020 | Allow | 10 | 1 | 0 | No | No |
| 16334562 | COPOLYMER COMPOSITION FOR COATING AND ADHESIVE APPLICATIONS | March 2019 | January 2023 | Abandon | 46 | 2 | 1 | No | No |
| 16334584 | COPOLYMER COMPOSITION FOR PERSONAL CARE | March 2019 | April 2022 | Abandon | 37 | 1 | 1 | No | No |
| 16289165 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | February 2019 | June 2019 | Allow | 3 | 1 | 0 | Yes | No |
| 16329534 | Coating of Nanoparticle Surfaces with Cyclopeptides for Improving Delivery of Agents Via the Oral Route | February 2019 | April 2021 | Abandon | 26 | 2 | 0 | No | No |
| 16327472 | COMPOSITION FOR ARTICULAR CAVITY INJECTION COMPRISING NUCLEIC ACID AND CHITOSAN | February 2019 | November 2021 | Allow | 32 | 2 | 0 | Yes | No |
| 16326606 | NON-VIRAL DELIVERY AGENTS FROM POLYELECTROLYTES BASED ON CYCLOPROPENIUM IONS, THEIR SYNTHESES, AND USES THEREOF | February 2019 | April 2022 | Abandon | 37 | 0 | 1 | No | No |
| 16274123 | COMPOSITIONS CONTAINING HC-HA/PTX3 COMPLEXES AND METHODS OF USE THEREOF | February 2019 | March 2020 | Allow | 13 | 2 | 0 | Yes | No |
| 16270206 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | February 2019 | May 2019 | Allow | 4 | 1 | 0 | Yes | No |
| 16323477 | COMPOSITION FOR THE TREATMENT OF A FUNGAL INFECTION | February 2019 | September 2023 | Abandon | 55 | 2 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FALKOWITZ, ANNA R.
With a 56.2% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 38.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner FALKOWITZ, ANNA R works in Art Unit 1617 and has examined 633 patent applications in our dataset. With an allowance rate of 49.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.
Examiner FALKOWITZ, ANNA R's allowance rate of 49.8% places them in the 13% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by FALKOWITZ, ANNA R receive 2.50 office actions before reaching final disposition. This places the examiner in the 69% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by FALKOWITZ, ANNA R is 33 months. This places the examiner in the 45% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +51.4% benefit to allowance rate for applications examined by FALKOWITZ, ANNA R. This interview benefit is in the 93% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 17.1% of applications are subsequently allowed. This success rate is in the 17% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 20.6% of cases where such amendments are filed. This entry rate is in the 27% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 26.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 30% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 70.4% of appeals filed. This is in the 57% percentile among all examiners. Of these withdrawals, 42.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 79.6% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.6% of allowed cases (in the 62% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.5% of allowed cases (in the 73% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.